BioSpace News Archive

Total Revenue Increased 34% in Second Quarter 2020 Compared to Second Quarter 2019 Despite COVID-19 Headwinds

Collaboration, Option and License Agreement Effective following HSR Clearance and $100 Million Up-Front Payment received by IDEAYA

Second quarter net sales of $166.5 million net of the retrospective one-time Acthar® Gel Medicaid liability; adjusted net sales of $700.9 million, a decline of 14.9%, due primarily to demand impacts related to COVID-19 and competitive and payer pressures on certain products

Methodist Le Bonheur Healthcare is the first hospital system globally to participate in a landmark study using a first-of-its-kind EEG device.

Haemonetics Corporation announced that financial results for its first quarter fiscal 2021, which ended June 27, 2020, are available on its Investor Relations website.

Everest Group PEAK Matrix Assessment Cites Cognizant’s Digital Transformation Capabilities, Thought Leadership Expertise and Healthcare Partnerships

ANA Therapeutics, a Silicon Valley-based biotech start-up announced that the U.S. Food and Drug Administration has cleared its investigational new drug application for ANA001 as a potential treatment for COVID-19, making it the first U.S.-based company to conduct a human clinical trial to determine the efficacy of niclosamide to treat COVID-19.

Balt to Commercialize Cerus Endovascular’s Contour Neurovascular System™ and Neqstent Coil Assisted Flow Diverter in Germany

Aurinia Pharmaceuticals Inc. announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 10, 2020 at 11:00 a.m. EDT.

AdaptHealth Corp., a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, announced financial results for the three- and six-month periods ended June 30, 2020.